Baseline characteristics, labour and perinatal outcomes of women according to maternal outcome.

<p>Baseline characteristics, labour and perinatal outcomes of women according to maternal outcome.</p

Coverage of key interventions^*.

<p>Coverage of key interventions^{<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0181470#t005fn001" target="_blank">*</a>}.</p

Frequency of potentially life-threatening disorders.

<p>Frequency of potentially life-threatening disorders.</p

Study profile.

<p>*) Sum of live births and stillbirths does not equal the total number of women because some of the included women had an abortion, did not deliver or data was missing from the patient file.</p

Convergent validity: association between overall rating of maternity care, and ReproQ score (all domains combined).

<p><a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0117031#pone.0117031.g002" target="_blank">Fig. 2A</a> shows the results during the antenatal phase; <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0117031#pone.0117031.g002" target="_blank">Fig. 2B</a> shows the results during labour and postnatal care. The overall rating (10-point VAS scale) was significantly associated with the overall ReproQ score (i.e. the unweighted summation [range 1–4] of the individual eight domains), in both the antepartum (p<0.001) and the postpartum phase (p<0.001).</p

Exploratory factor analysis of the ReproQ (antenatal, delivery, and postpartum responses separately).

<p>Adaptation: NC = no change; AI = adjusted item; AR = adjusted response mode; DD = assigned to different domain based on EFA; DEL = removed</p><p>* The last three columns represent 3 separate factor analyses. The number of the factor is listed in the order of the output (F1 = first factor, F2 = second factor, etc). Only results with a factor loading > 0.3 are shown. If an item corresponds to a factor numbers in italics, then the factor analysis apparently placed the item into another domain, as we assumed constructing the item cf. the WHO domain structure.</p><p>** For reasons of brevity, we indicate the contents of each item as a professional or maternity care organization characteristic. The question to the respondent refers to the actual experience. E.g. the first item indicated with “respecting privacy”, in the ReproQ reads as “Did the caregiver consider your privacy during care provision?”</p><p>Exploratory factor analysis of the ReproQ (antenatal, delivery, and postpartum responses separately).</p

Characteristics of the participating women in the preparatory interview study and the ReproQ survey study.

<p>Characteristics of the participating women in the preparatory interview study and the ReproQ survey study.</p

Receiver operating characteristic curves (ROCs) with prediction models for a) EO-PE, b) EO-PE with SGA, c) LO-PE, d) LO-PE with SGA.

<p>(- - - -) Prior risk of preeclampsia containing maternal characteristics, (_____) prior risk for preeclampsia combined with all markers: Pregnancy-Associated Plasma Protein-A (PAPP-A), A Disintegrin And Metalloproteinase 12 (ADAM12), Placental Growth Factor (PlGF) and Mean Arterial Pressure (MAP).</p

Supplemental material for Association of Maternal Prepregnancy Body Mass Index With Placental Histopathological Characteristics in Uncomplicated Term Pregnancies

<p>Supplemental material for Association of Maternal Prepregnancy Body Mass Index With Placental Histopathological Characteristics in Uncomplicated Term Pregnancies by Laura Brouwers, Arie Franx, Tatjana E Vogelvang, Michiel L Houben, Bas B van Rijn and Peter GJ Nikkels in Pediatric and Developmental Pathology</p

Model predicted early preeclampsia detection rate (95% CI) for FPR of 5 and 10% with PAPP-A, fβ–hCG, ADAM12, PlGF and MAP in control and preeclampsia groups.

<p>FPR: false positive rate; PAPP-A: Pregnancy-Associated Plasma Protein-A; fβ–hCG: free β–human Chorionic Gonadotropin; ADAM12: A Disintegrin And Metalloprotease 12; PlGF: Placental Growth Factor; MAP: Mean Arterial Pressure; EO-PE: early-onset preeclampsia; LO-PE: late-onset preeclampsia; SGA: small-for-gestational age.</p